DLK1 and Nesfatin-1 levels and the relationship with metabolic parameters in polycystic ovary syndrome: Prospective, controlled study

Caltekin, Melike; Caniklioglu, AYŞEN; Yalcin, Serenat; Kirmizi, Demet; BAŞER, EMRE; YALVAÇ, ETHEM

doi:10.4274/tjod.galenos.2021.39024

DLK1 and Nesfatin-1 levels and the relationship with metabolic parameters in polycystic ovary syndrome: Prospective, controlled study

Caltekin M. D. , Caniklioglu A. , Yalcin S. E. , Kirmizi D. A. , BAŞER E., YALVAÇ E. S.

TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, vol.18, no.2, pp.124-130, 2021 (Journal Indexed in ESCI)

Publication Type: Article / Article
Volume: 18 Issue: 2
Publication Date: 2021
Doi Number: 10.4274/tjod.galenos.2021.39024
Title of Journal : TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY
Page Numbers: pp.124-130

Abstract

Objective: Delta-like 1 (DLK1) is known to inhibit adipocyte differentiation and nesfatin-1 is a neuropeptide that plays a role in the regulation of nutrition and metabolism. We aimed to assess both the levels of DLK1 and nesfatin-1 in polycystic ovary syndrome (PCOS) and determine the association of DLK1 and nesfatin-1 with metabolic parameters.